Natural Remedies has been awarded the 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award by the American Botanical Council, recognising the company's sustained commitment to clinical research across multiple medicinal plants.
Dr Suresh Lakshmikanthan, Chief Business Officer at Natural Remedies, accepted the award at the Botanical Excellence Awards ceremony on March 3rd at Natural Products Expo West.
"What stands out about Natural Remedies is the depth and consistency of its investment in human clinical research," said Mark Blumenthal, founder and Executive Director of the American Botanical Council.
The company has taken a long-term view, applying rigorous scientific methods to botanicals with global relevance and helping advance a more credible and evidence-based foundation for various traditionally used herbal medicines.
Natural Remedies has made a significant investment in clinical research focused on various botanicals that have both traditional uses and emerging clinical evidence.
The company consistently employs rigorous study designs to investigate how plants such as holy basil, turmeric, bacopa, andrographis and liquorice can impact human health, effectively integrating traditional knowledge with modern science.
"We are deeply honoured to receive this award from the American Botanical Council," said Anurag Agarwal, Managing Director, Natural Remedies.
This recognition reflects our steadfast commitment to scientific integrity, rigorous research and advancing evidence-based botanicals globally.
"We are grateful to the American Botanical Council for upholding the highest standards of excellence in the herbal industry."
The award reflects ABC's longstanding mission to advance responsible research, education and quality standards in herbal medicine and is named after the late Professor Varro E. Tyler, former dean of the School of Pharmacy and Pharmacal Sciences at Purdue University and an early member of the ABC's Board of Trustees.
Tyler helped shape the organisation's early publications and programmes in pharmacognosy, ethnobotany and botanical education, including work related to ABC's English translation and publication of the German Commission E Monographs.
Blumenthal noted that Natural Remedies was selected for its strong commitment to scientific and clinical research on botanicals such as andrographis, bacopa, holy basil, liquorice and turmeric.
With more than 20 published human clinical trials, the company has explored traditional and emerging health applications, including support for cold and flu, cognitive function, digestive health, joint comfort and stress resilience.